Overview
PGNY market data
Price History
PGNY price chart
Valuation & Profitability
- P/E (TTM)
- 25.37 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.65 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.01 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 6.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.10 – $33.07 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2B · P/B 4.29 · P/S 1.52.
Company News
Truist Securities Maintains Buy on Progyny, Raises Price Target to $36Benzinga · Aug 13, 2026, 3:49 PM
Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30Benzinga · Aug 12, 2026, 12:37 PM
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth ConferenceGlobenewswire Inc · Aug 7, 2026, 3:15 PM
12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · Aug 7, 2026, 12:05 PM
Progyny shares are trading lower after the company reported Q2 financial results and lowered its FY26 sales guidance with its midpoint below estimates. Also, the company issued Q3GAAP EPS and sales guidance below estimates.Benzinga · Aug 7, 2026, 11:36 AM
12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga · Aug 6, 2026, 9:06 PM
Progyny Sees Q3 GAAP EPS $0.30-$0.33 vs $0.34 EstBenzinga · Aug 6, 2026, 8:05 PM
Progyny Sees Q3 Adj EPS $0.50-$0.52 vs $0.33 Est; Sees Sales $335.000M-$345.000M vs $350.185M EstBenzinga · Aug 6, 2026, 8:05 PM
Progyny Narrows FY2026 GAAP EPS Guidance from $1.23-$1.34 to $1.26-$1.32 vs $1.29 EstBenzinga · Aug 6, 2026, 8:02 PM
Progyny Raises FY2026 Adj EPS Guidance from $1.98-$2.09 to $2.04-$2.10 vs $1.29 Est; Lowers FY2026 Sales Guidance from $1.365B-$1.405B to $1.360B-$1.385B vs $1.384B EstBenzinga · Aug 6, 2026, 8:02 PM